T 0601/05 (Anti-TNF alpha human monoclonal antibodies/BAYER III) vom 02.12.2009
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2009:T060105.20091202
- Datum der Entscheidung
- 2. Dezember 2009
- Aktenzeichen
- T 0601/05
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 94102560.3
- IPC-Klasse
- C07K 16/24
- Verfahrenssprache
- Englisch
- Verteilung
- An die Kammervorsitzenden verteilt (C)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- T 0601/05 Anti-TNF alpha human monoclonal antibodies/BAYER I 2007-10-18T 0601/05 Anti-TNF alpha human monoclonal antibodies/BAYER II 2008-04-24
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Anti-TNF alpha human monoclonal antibodies
- Name des Antragstellers
- Bayer Corporation
- Name des Einsprechenden
- Centocor, Inc.
Abbott Laboratories - Kammer
- 3.3.04
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 113(1)European Patent Convention Art 114(2)European Patent Convention Art 116European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 57European Patent Convention Art 83European Patent Convention Art 84
- Schlagwörter
- Admission of late-filed documents - (partly)
Admission of late-filed auxiliary requests 1 to 3 - (no)
Main request - sufficiency of disclosure - (no)
Auxiliary request 4 - added matter, extension of scope (no); clarity and support (yes); sufficiency of disclosure, novelty, inventive step (yes)
Right to be heard violated by (i) non-admission of parts of documents and (ii) limitation of time to speak at oral proceedings (no) - Orientierungssatz
- see points 11 to 17, 21 to 44 and 121 to 126
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the following documents:
Claims: 1 to 4 of auxiliary request 4 filed at the oral proceedings.
Description: page 3 filed at the oral proceedings;
pages 4 to 18 of the patent specification.
Figures: 1 to 12 of the patent specification.